Archives for May 2, 2007

← 2007

Latest in Covance and GSKs' tussles with animal rights organisations

By  Kirsty Barnes

This week Covance has paid PETA Europe's court costs relating back to a failed legal bid to prevent the broadcast of video footage taken during a covert investigation of its US animal laboratory. Meanwhile, GSK has had a positive result in extending a...

Prosonix wins award for SAX

By  Dr Matt Wilkinson

Prosonix and Bath University in the UK have won the Royal Society of Chemistry's (RSC) Innovation award for the development of a tool that enables the manufacture of crystalline pharmaceuticals of specific sizes.

One-off costs slice Millipore profits in Q1

By  Peter Mansell

One-off costs related to last year's acquisition of Serologicals and a continuing manufacturing consolidation strategy were largely responsible for sharp falls in Millipore's pre-tax and net profits for the first quarter ended 31 March 2007.

Big bucks for BMS biologics base

By  Anna Lewcock

Construction has finally begun on Bristol-Myers Squibb's (BMS) new biologics manufacturing facility in Massachusetts, with the company upping its original investment estimates for construction from $660m (€485.7m) to $750m.

SAFC completes protein purification capacity expansion

By  Emilie Reymond

SAFC Pharma, the contract manufacturing arm of Sigma-Aldrich, has announced it has completed the construction of two protein active pharmaceutical ingredient (API) facilities at its US manufacturing site.

VWR changes hands again

By  Dr Matt Wilkinson

VWR's parent company has signed a definitive agreement to sell the world's second largest laboratory supplier after its recent period of significant growth and profitability.

Xceleron to accelerate growth further

By  Dr Matt Wilkinson

Not content with doubling its revenues over the past year, Xceleron is pushing for even more growth by hiring new business development personnel.

Bosch plans to snap up Pharmatec

By  Anna Lewcock

The Bosch Group has announced plans to augment its packaging technology division with the acquisition of German firm Pharmatec.

New facility for Althea one step closer

By  Anna Lewcock

Technology and services provider Althea Technologies has stepped closer to a significant increase in manufacturing capacity as it announces the completion of the first phase of construction at its new San Diego facility.